The collaboration will leverage Genesis' GEMS or Genesis Exploration of Molecular Space artificial intelligence or AI platform to discover and optimize novel therapeutics for Incyte-selected targets.

The company’s fifty day moving average price ... of Genesis Energy by 2.9% during the 3rd quarter. Captrust Financial Advisors now owns 31,720 shares of the pipeline company’s stock valued ...

We recently published a list of 12 AI Updates Worth Taking a Look At. In this article, we are going to take a look at where Incyte Corporation (NASDAQ:INCY) stands against other AI updates worth ...

In this article, we are going to take a look at where Genesis ... AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an ...

For this article, we selected AI stocks by reviewing news articles, stock analysis ... On February 20, Incyte and Genesis Therapeutics formed a collaboration to develop novel small-molecule ...